Palbociclib (PD-0332991) HCl
Palbociclib (PD-0332991) HCl is a highly selective inhibitor of CDK4/6 with IC50 of 11 nM/16 nM in cell-free assays, respectively. It shows no activity against CDK1/2/5, EGFR, FGFR, PDGFR, InsR, etc. Phase 3.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | S1116 |
| Sku # | S1116-50mg |
| Pricing | 50mg, $570.00 |
Citations for this product:
-
bioRxiv - Cancer Biology 2020Quote: ... palbociclib (Selleck Chemicals #S1116).
-
bioRxiv - Cell Biology 2019Quote: ... CDK4/6 inhibitor PD0332991 (Palbociclib) at 1μM unless indicated otherwise (Selleck Chemicals S1116), CDK4/6 inhibitor LY2835219 (Abemaciclib ...
-
bioRxiv - Pharmacology and Toxicology 2019Quote: The CDK4/6 inhibitor palbociclib (PD0332991) was purchased from Selleck Chemicals (#S1116; USA) and dissolved in double-distilled H2O as a stock solution at concentration of 10 mM ...
-
bioRxiv - Cancer Biology 2019Quote: Chemicals utilized included palbociclib (Selleck Chemicals, S1116), abemaciclib (ApexBio ...
-
bioRxiv - Cancer Biology 2024Quote: ... palbociclib (Selleck Chemical; S1116), roscovitine (Selleck Chemical ...
-
bioRxiv - Cancer Biology 2022Quote: ... at 10μM (cat#S1116 From Selleck Chemicals) were administered at times 0 and 72 hours ...